Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Contrast Media & Molecular Imaging
|
March 28, 2007
MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent
Olaf Saborowski, Gerhard H Simon, Hans-Juergen Raatschen, et al.
European Journal of Radiology
|
April 8, 2011
Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration
Shinn-Huey Chou, Zhen J Wang, Jonathan Kuo, et al.
Abdominal Radiology (New York)
|
February 3, 2016
Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration
Gregory E Tong, Sant Kumar, Karen C Chong, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 3, 2024
In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases-co-producing carbapenem-resistant Enterobacter cloacae complex
Wengang Li, Jisheng Zhang, Yanjun Fu, et al.
European Radiology
|
January 9, 2007
Cell labeling with the positive MR contrast agent Gadofluorine M
Tobias D Henning, Olaf Saborowski, Daniel Golovko, et al.
Contrast Media & Molecular Imaging
|
December 29, 2006
MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agent
Hans-Jürgen Raatschen, Rebecca Swain, David M Shames, et al.
Radiology
|
February 29, 2008
Physiology of renal medullary tip hyperattenuation at unenhanced CT: urinary specific gravity and the NaCl concentration gradient
Christopher T Hsu, Zhen J Wang, Alan S L Yu, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Contrast Media & Molecular Imaging
|
March 28, 2007
MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent
Olaf Saborowski, Gerhard H Simon, Hans-Juergen Raatschen, et al.
European Journal of Radiology
|
April 8, 2011
Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration
Shinn-Huey Chou, Zhen J Wang, Jonathan Kuo, et al.
Abdominal Radiology (New York)
|
February 3, 2016
Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration
Gregory E Tong, Sant Kumar, Karen C Chong, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 3, 2024
In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases-co-producing carbapenem-resistant Enterobacter cloacae complex
Wengang Li, Jisheng Zhang, Yanjun Fu, et al.
European Radiology
|
January 9, 2007
Cell labeling with the positive MR contrast agent Gadofluorine M
Tobias D Henning, Olaf Saborowski, Daniel Golovko, et al.
Contrast Media & Molecular Imaging
|
December 29, 2006
MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agent
Hans-Jürgen Raatschen, Rebecca Swain, David M Shames, et al.
Radiology
|
February 29, 2008
Physiology of renal medullary tip hyperattenuation at unenhanced CT: urinary specific gravity and the NaCl concentration gradient
Christopher T Hsu, Zhen J Wang, Alan S L Yu, et al.
Page
of 7